MARINOL
What it isSynthetic delta-9-THC and CB1 agonist; chemotherapy nausea and appetite stimulation in AIDS.
Why this oneIt provides a measured single-cannabinoid product rather than the variable mixture delivered by inhaled cannabis.
What limits itDysphoria, dizziness, and tachycardia are worst in older adults; oral absorption is slow and variable, and it is Schedule III.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Anorexia with weight loss in AIDS | Adults | 2.5 mg BID | 2.5–5 mg BID | 10 mg BID |
| Chemotherapy-induced nausea/vomiting (refractory) | Adults | 5 mg/m² pre-chemo, then q2–4h | 5 mg/m² q2–4h | 4–6 doses/day |
Titration AIDS anorexia: increase gradually (e.g., 2.5 mg AM / 5 mg PM, then 5 mg BID) as tolerated.
Renal Undefined
Hepatic Undefined
CINV: repeat every 2–4 h after chemotherapy, 4–6 doses per day.
Pregnancy May cause fetal harm; avoid use in pregnancy
Lactation HIV-infected women advised not to breastfeed (HIV transmission); monitor infant weight where breastfeeding appropriate
NO BOXED WARNINGS
Principal riskDysphoria and dizziness, worst in the elderly
Cost, est. cash$10–$300/month
Generic entry2008
Legacy pregnancy categoryC
Defining liabilitySedation, QT prolongation, extrapyramidal symptoms or anticholinergic toxicity vary by receptor target.

Open Dronabinol in the interactive console ↗
